Karolina F. Larsson
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Tolerability and adherence to adjuvant abemaciclib in hormone receptor-positive, HER2-negative, node-positive high-risk early breast cancer: a real-world study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 19, 2026
Making patient-oriented decisions with collegial support as an anchor: Oncologists' experiences of late-line treatment selection in metastatic breast cancer.
Journal: Patient education and counseling
Published: March 28, 2026
PIK3CA mutation testing and alpelisib use in metastatic breast cancer: a real-world data set.
Journal: Acta oncologica (Stockholm, Sweden)
Published: February 18, 2026
Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors.
Journal: Breast cancer research and treatment
Published: October 13, 2025
Plasma extracellular vesicles reflect response and prognosis in patients with breast cancer undergoing neoadjuvant treatment.
Journal: Breast cancer research : BCR
Published: July 24, 2025
The outcome of selective delayed sentinel lymph node biopsy following upfront omission of axillary staging in low-risk invasive breast cancers: a retrospective hypothetical simulated analysis.
Journal: Discover oncology
Published: February 24, 2025
Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements.
Journal: International journal of cancer
Published: October 09, 2024
The impact of high exposure to perfluoroalkyl substances and risk for hormone receptor-positive breast cancer - A Swedish cohort study.
Journal: Environment international
Published: June 19, 2024
Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trial.
Journal: Breast (Edinburgh, Scotland)
Published: April 23, 2024
Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens.
Journal: BMC cancer
Published: November 13, 2020
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
Journal: Cancer discovery
Published: November 11, 2020
Efficacy and tolerability of metronomic chemotherapy in patients with metastatic breast cancer - an international experience in West Sweden and in the South of Ireland.
Journal: Cancer treatment and research communications
Published: October 06, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026